All Research on Pharmaceuticals and Healthcare in Japan

Insight

Brief
Brief

The Evolving Landscape in Biosimilars

Biosimilars offer significant opportunities, but only players with well-positioned offerings will see success in this challenging segment.

Published By Datamonitor
$1200
Buy
Report
Report

The Hepatitis C Market Outlook to 2022

The hepatitis C market will experience a boom as revolutionary interferon-free regimens arrive.

Published By Datamonitor
$2800
Buy
Report
Report

The Inflammatory Bowel Disease Market Outlook to 2021

The IBD market is set to experience considerable change over the next ten years. A number of significant new product launches will reshape the market, with sales for ulcerative colitis forecast to overtake those for Crohn's disease.

Published By Datamonitor
$2800
Buy

View all Insight >>

Market Data

Interactive Model
Interactive Model

The Depression Market Forecast to 2021

The expected Q4 2013 launches of Brintellix and levomilnacipran will occur against a backdrop of a declining market.

Published By Datamonitor
$6400
Buy
Interactive Model
Interactive Model

The Hepatitis C Market Forecast to 2022

The hepatitis C market will experience a boom as revolutionary interferon-free regimens arrive.

Published By Datamonitor
$6400
Buy
Interactive Model
Interactive Model

The Inflammatory Bowel Disease Market Forecast to 2021

The IBD market is set to experience considerable change over the next ten years. A number of significant new product launches will reshape the market, with sales for ulcerative colitis forecast to overtake those for Crohn's disease.

Published By Datamonitor
$6400
Buy

View all Market Data >>

Profiles

Company Profile
Company Profile

Nitto Boseki Co., Ltd.

Nitto Boseki Co., Ltd. (Nittobo or 'the company') is engaged in the manufacture of glass fiber products, environment, building materials, textiles, medical products, beverages and specialty chemicals. The company primarily operates in Japan. The company operates in Asia-Pacific, North America and Europe and other regions. It is headquartered in Tokyo and employed 2,530 people as on March 31, 2014.

Published By MarketLine
$175
Buy
Company Profile
Company Profile

Eisai Co., Ltd.

Eisai (or 'the group') is engaged in manufacturing and marketing of pharmaceutical products. The group primarily operates in Japan, the US and Europe. It is headquartered in Tokyo, Japan, and employed 10,419 people as on March 31, 2014.

Published By MarketLine
$175
Buy
Company Profile
Company Profile

Toray Industries, Inc.

Toray Industries (Toray or 'the group') is engaged in manufacturing, processing and selling chemical products worldwide. The group primarily operates in Asia, North America and Europe. It is headquartered in Tokyo, Japan, and employed 45,881 people as of March 31, 2014.

Published By MarketLine
$175
Buy

View all Profiles >>

No help is available.